Publications » Search Results » 2011 » Publications indexed in Scopus database

 2017  2016  2015  2014  2013  2012  2011  2010  2009  2008  2007  2006  2005  2004  2003  2002  2001  2000  1999  1998  1997  1996  1995  1994  1993  1992  1991  1990  1989  1988  1987  1986  1985  1984  1983  1982  1981  1980  1979  1978  1977  1976  1975  1974  1973  1972  1971  1970  1969  1968  1967  1966  1965  1964  1962
Show per page  
31*Swarbrick J.D.; Ung P.; Su X.-C.; Maļeckis A.; Chhabra S.; Huber T.; Otting G.; Graham B. Engineering of a bis-chelator motif into a protein α-helix for rigid lanthanide binding and paramagnetic NMR spectroscopy. Chem. Commun. 2011, 47(26), 7368-7370.      

32*Habarova O.; Bobijeva O.; Loža E.; Romančikova N. Synthesis of 2-quinolinecarboxamide derivatives as potential HDAC inhibitors. Khim. Geterotsikl. Soedin. 2011(6), 871-880.      

33*Lakevics V.; Locs J.; Loča D.; Stepanova V.; Berzina-Cimdina L.; Pelšs J. Bioceramic hydroxyapatite granules for purification of biotechnological products. Adv. Mater. Res. 2011, 284-286, 1764-1769.      

34*Pelšs J.; Loča D.; Berzina-Cimdina L.; Locs J.; Lakevics V. Release of anticancer drug doxorubicin from biodegradable polymer coated porous hydroxyapatite scaffolds. Adv. Mater. Res. 2011, 284-286, 1770-1773.      

35*Potoročina I.; Vorona M.; Shestakova I.; Domrachova I.; Lie Pinsh E.; Veinberg G. Synthesis and biological activity or alkylidene-substituted cephems and penams. Khim. Geterotsikl. Soedin. 2011(6), 928-938.      

36Pajuste K.; Gosteva M.; Kaldre D.; Plotniece M.; Čekavičus B.; Sobolev A.; Priksane A.; Tirzītis G.; Duburs G.; *Plotniece A. Effect of the solvent nature on the course of quaternization of 3,5-diethoxycarbonyl-2,6-dimethyl-4-(3-pyridyl)-1,4-dihydropyridine. Chem. Heterocycl. Compd. 2011, 47(5), 597-601.      

37*Arsenyan P.; Paegle E.; Belyakov S.; Shestakova I.; Jaschenko E.; Domracheva I.; Popelis J. Synthesis, structure and cytotoxicity of 3-C, N, S, Se substituted benzo[b]selenophene derivatives. Eur. J. Med. Chem. 2011, 46(8), 3434-3443.      

38*Belyakov S.; Arhangelskis M.; Zielonka M.; Erchak N. Crystal structure of 1-(N-morpholiniomethyl)spirobi(4-methyl-3-oxo-2,5- dioxa-1-silacyclopentan)ate dihydrate, C 11H 19NO 7Si · 2H 2O. Z. Kristallograph. New Cryst. Struct. 2011, 226(2), 237-238.      

39*Garaliene V.; Barsys V.; Jakuska P.; Krauze A.; Duburs G. Effects of calcium antagonists and agonists on isolated human v. saphena magna used for coronary artery bypass grafting and guinea pig's papillary muscle. ARZNEIM.-FORSCH. DRUG RES. 2011, 61(7), 386-392.      

40*Vilšķērsts R.; Kūka J.; Švalbe B.; Cīrule H.; Liepinsh E.; Grinberga S.; Kalvinsh I.; Dambrova M. Administration of L-carnitine and mildronate improves endothelial function and decreases mortality in hypertensive Dahl rats. Pharmacol. Rep. 2011, 63(3), 752-762.      

Show per page